Trial of Hydrocortisone for Post-Traumatic Stress Disorder (PTSD)

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Post-traumatic Stress Disorder

In brief

Developing novel and effective pharmacologic interventions for this post-traumatic stress disorder is important. The investigators propose to replicate findings of an earlier published pilot study using low dose hydrocortisone as a treatment for PTSD. In order to do so in a more meaningful way, the investigators will conduct a larger but similar randomized double-blind placebo-controlled, cross-over design treatment study examining the use of low dose hydrocortisone (or placebo) for 4 weeks in combat veterans suffering from PTSD. The investigators hypothesize that, as described by Aerni et al. (2004), administration of daily hydrocortisone will lead to a reduction in PTSD symptom severity, but particularly for re-experiencing types (e.g., flashbacks, nightmares)of symptoms. The investigators also hope to examine potential predictors and moderators of treatment response based on subjects' clinical characteristics, as well as serum cortisol and ACTH levels.

Key facts

Study ID

NCT00706173

Run by

University of California, San Diego

People needed

0

Starts

2009-08-01

Expected to finish

2011-09-01

Last updated by the study team

2015-06-03

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male military veterans
• Between the ages of 18-65 years old
• Generally good medical health with no clinically significant abnormalities on physical examination, electrocardiogram, or laboratory findings
• Ability to provide informed consent and comply with requirements of study protocol
• No specific contraindications to hydrocortisone
• Clinically predominant DSM-IV diagnosis of PTSD
• Score of ≥ 40 on Clinician Administered PTSD Scale [CAPS]

You may not qualify if…

• History of moderate to severe traumatic brain injury, seizure or organic mental illness
• Lifetime history of schizophrenia, bipolar disorder, other psychotic disorder, or depression with a score of ≥ 16 on the 17-item Hamilton Depression Rating Scale (Hamilton, 1960), active suicidal ideation
• Unstable medical illness
• Subjects undergoing any formal psychotherapy within 3 months of enrollment
• Subjects that meet criteria for substance dependence during the last 6 months
• History of adverse reaction to corticosteroids.
• Concurrent use of other psychotropic medication (e.g. benzodiazepines, antipsychotics)

Where it is running

• University of California, San Diego — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.